Skip to main content
58 results for: intellectual property
gavel
July 23, 2026

Innovation Brings Attention: 5 Litigation Risks Growing Technology Companies Should Watch

By Jon McMichael
Seattle Tech Week returns July 27-31, and litigation risk is one topic we hear about from growing companies. The data below shows why litigation preparedness belongs next to product and fundraising strategy, not behind it.
gavel
July 23, 2026

Innovation Brings Attention: 5 Litigation Risks Growing Technology Companies Should Watch

By Jon McMichael
Seattle Tech Week returns July 27-31, and litigation risk is one topic we hear about from growing companies. The data below shows why litigation preparedness belongs next to product and fundraising strategy, not behind it.
A semiconductor chip labeled "AI" on a circuit board.
June 04, 2026

Navigating AI Liability Under the Revised NO FAKES Act

By Allyson Madrid
A bipartisan group of senators introduced a revised version of the NO FAKES Act on May 20, 2026, marking a federal legislative effort to protect individuals’ voices and visual likenesses from unauthorized AI-generated digital replicas.
A semiconductor chip labeled "AI" on a circuit board.
June 04, 2026

Navigating AI Liability Under the Revised NO FAKES Act

By Allyson Madrid
A bipartisan group of senators introduced a revised version of the NO FAKES Act on May 20, 2026, marking a federal legislative effort to protect individuals’ voices and visual likenesses from unauthorized AI-generated digital replicas.
Closeup of the hands from "Creation of Man" from the Sistine Chapel, with a robot hand replacing Adam's
May 06, 2026

Introducing ‘Down the Gradient’: Where AI Meets Law and Real Conversation

By Adine Mitrani, Anthony T. Jacobson

There’s no shortage of AI content across headlines and timelines, but not all of it feels like real, practical conversation.

Closeup of the hands from "Creation of Man" from the Sistine Chapel, with a robot hand replacing Adam's
May 06, 2026

Introducing ‘Down the Gradient’: Where AI Meets Law and Real Conversation

By Adine Mitrani, Anthony T. Jacobson

There’s no shortage of AI content across headlines and timelines, but not all of it feels like real, practical conversation.

A gaming PC and peripherals.
March 10, 2026

Mass Arbitrations: The Legal Risk Most Game Studios Don’t See Coming

By Kimberly Culp, Molly Melcher

Leading up to this year’s Game Developers’ Conference, most legal conversations will focus on AI, IP ownership, and platform de

A gaming PC and peripherals.
March 10, 2026

Mass Arbitrations: The Legal Risk Most Game Studios Don’t See Coming

By Kimberly Culp, Molly Melcher

Leading up to this year’s Game Developers’ Conference, most legal conversations will focus on AI, IP ownership, and platform de

video games controllers
March 02, 2026

What Games Lawyers Actually Do (And Why It Matters for Your Studio)

By Joseph Schenck, Katherine Duncan, Eric Ball
Video games are built on creativity, connection, and risk-taking. The legal work that supports them isn’t all that different.
video games controllers
March 02, 2026

What Games Lawyers Actually Do (And Why It Matters for Your Studio)

By Joseph Schenck, Katherine Duncan, Eric Ball
Video games are built on creativity, connection, and risk-taking. The legal work that supports them isn’t all that different.
science
January 21, 2026

Building an Exit-Ready IP Profile: Considerations for Companies That Attended JPM and Beyond

By Heidi Erlacher, Matthew Pavao
As life sciences companies mature, intellectual property often becomes both their most valuable and most scrutinized asset.
science
January 21, 2026

Building an Exit-Ready IP Profile: Considerations for Companies That Attended JPM and Beyond

By Heidi Erlacher, Matthew Pavao
As life sciences companies mature, intellectual property often becomes both their most valuable and most scrutinized asset.
biotechnology
January 13, 2026

Closing the Gaps: IP Strategies for Biotechs Ahead of Fundraising or Partnering

By Heidi Erlacher, Matthew Pavao
As early-stage life sciences companies prepare for their next financing or partnership, intellectual property due diligence is often the first, and most consequential, checkpoint.
biotechnology
January 13, 2026

Closing the Gaps: IP Strategies for Biotechs Ahead of Fundraising or Partnering

By Heidi Erlacher, Matthew Pavao
As early-stage life sciences companies prepare for their next financing or partnership, intellectual property due diligence is often the first, and most consequential, checkpoint.
abstract
January 07, 2026

Strengthening Life Sciences IP Before Going Clinical

By Heidi Erlacher, Matthew Pavao
Transitioning from discovery to clinical development marks a defining moment for emerging biotech companies. It’s also a time to consider evolving your IP strategy from protecting ideas to protecting assets.
abstract
January 07, 2026

Strengthening Life Sciences IP Before Going Clinical

By Heidi Erlacher, Matthew Pavao
Transitioning from discovery to clinical development marks a defining moment for emerging biotech companies. It’s also a time to consider evolving your IP strategy from protecting ideas to protecting assets.
green and blue design of courthouse and documents in a circle
October 02, 2025

Federal Circuit Ruling Highlights Licensing and Damages Pitfalls for Technology and Life Sciences Companies

By Jon McMichael

Patent licensing, monetization, and damages are full of potential pitfalls for IP holders, prospective licensees, and even comp

green and blue design of courthouse and documents in a circle
October 02, 2025

Federal Circuit Ruling Highlights Licensing and Damages Pitfalls for Technology and Life Sciences Companies

By Jon McMichael

Patent licensing, monetization, and damages are full of potential pitfalls for IP holders, prospective licensees, and even comp